MedTrace Logo

Observational Study to Evaluate the BioMimics 3D Stent System: MIMICS-3D

NCT02900924 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 507

Last updated 2025-04-17

Study results available
· View outcomes & findings →

Summary

The MIMICS-3D study will evaluate safety, effectiveness and device performance within a real-world clinical population of patients undergoing femoropopliteal intervention.

Conditions

  • Peripheral Arterial Disease

Interventions

DEVICE

BioMimics 3D Stent

Sponsors & Collaborators

  • Veryan Medical Ltd.

    lead INDUSTRY

Principal Investigators

  • Michael Lichtenberg, MD · Klinikum Arnsberg

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2019-10-31
Completion
2021-09-30

Countries

  • Belgium
  • Germany
  • Netherlands
  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02900924 on ClinicalTrials.gov